CorMedix (CRMD) Non-Current Deffered Revenue (2010 - 2015)
CorMedix's (CRMD) quarterly Non-Current Deffered Revenue came in at $28878.0 in Q4 2015, up 163.65% quarter-over-quarter from $10953.0 in Q1 2013.
CorMedix (CRMD) Non-Current Deffered Revenue (2010 - 2015) Analysis & Trends
CorMedix has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $28878.0 for Q4 2015.
- Non-Current Deffered Revenue for Q4 2015 came in at $28878.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $28878.0 (changed N/A YoY), and the FY2015 annual result was $28878.0, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $28878.0 for Q4 2015 at CorMedix, up from $10953.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $28878.0 in Q4 2015 to a low of $10953.0 in Q1 2013.
- The 4-year median for Non-Current Deffered Revenue is $13900.0 (2012), against an average of $15236.9.
- Across the five-year window, Non-Current Deffered Revenue decreased 13.65% in 2011 and retreated 21.2% in 2013, its largest moves.
- CorMedix's Non-Current Deffered Revenue stood at $14472.0 in 2011, then decreased by 15.8% to $12185.0 in 2012, then retreated by 10.11% to $10953.0 in 2013, then soared by 163.65% to $28878.0 in 2015.
- The last three Non-Current Deffered Revenue figures came in at $28878.0 (Q4 2015), $10953.0 (Q1 2013), and $12185.0 (Q4 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 28,878.00 |
| Mar 31, 2013 | 10,953.00 |
| Dec 31, 2012 | 12,185.00 |
| Sep 30, 2012 | 12,756.00 |
| Jun 30, 2012 | 13,328.00 |
| Mar 31, 2012 | 13,900.00 |
| Dec 31, 2011 | 14,472.00 |
| Sep 30, 2011 | 15,044.00 |
| Jun 30, 2011 | 15,616.00 |
| Dec 31, 2010 | 16,759.00 |